{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:29:11Z","timestamp":1791044951866,"version":"4.1.0"},"reference-count":63,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Adrenal hyperfunction is associated with an increased risk of cardiometabolic complications in subjects with adrenal incidentaloma (AI). Reliable prevalence estimates of functioning AIs are important to direct resources allocations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To assess the prevalence of autonomous\/possible autonomous cortisol secretion (ACS), primary aldosteronism (PA), pheochromocytoma (PHEO), and Cushing syndrome (CS) in patients with AI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a comprehensive search of multiple databases (PubMed, Ovid MEDLINE, Web of Science) for potentially relevant studies without language restriction, up to February 2022. Of the 1661 publications evaluated at title and abstract levels, 161 were examined as full text and 36 were included. Study level clinical data were extracted by 3 independent reviewers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The overall prevalence of functioning AIs was 27.5% (95% CI 23.0, 32.5). ACS\/possible ACS, with a prevalence of 11.7% (95% CI 8.6, 15.7), was the most frequent hormonal alteration, while PA occurred in 4.4% of the patients (95% CI 3.1, 6.2). Subgroup analysis showed that PA was more prevalent in patients from Asia than in patients from Europe\/America; in contrast, ACS\/possible ACS had a lower prevalence in Asian countries. At meta-regression analysis, the prevalence of ACS\/possible ACS was influenced by the proportion of female patients, while the prevalence of PA was positively associated with the proportion of patients with hypertension and the publication year. Finally, PHEO and CS prevalence were 3.8% (95% CI 2.8, 5.0) and 3.1% (95% CI 2.3, 4.3) respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This meta-analysis provides extensive data on the prevalence of functioning AIs and the factors affecting heterogeneity in prevalence estimates.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgad044","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T18:25:11Z","timestamp":1675189511000},"page":"1813-1823","source":"Crossref","is-referenced-by-count":46,"title":["Prevalence of Functioning Adrenal Incidentalomas: A Systematic Review and Meta-analysis"],"prefix":"10.1210","volume":"108","author":[{"given":"Elisa","family":"Sconfienza","sequence":"first","affiliation":[{"name":"Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino , Via Genova 3, 10126 Torino , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Tetti","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino , Via Genova 3, 10126 Torino , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Forestiero","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino , Via Genova 3, 10126 Torino , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5239-6890","authenticated-orcid":false,"given":"Franco","family":"Veglio","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino , Via Genova 3, 10126 Torino , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5480-1116","authenticated-orcid":false,"given":"Paolo","family":"Mulatero","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino , Via Genova 3, 10126 Torino , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7322-2005","authenticated-orcid":false,"given":"Silvia","family":"Monticone","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino , Via Genova 3, 10126 Torino , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"issue":"4","key":"2023061601030595700_dgad044-B1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF03344099","article-title":"Prevalence of adrenal incidentaloma in a contemporary computerized tomography series","volume":"29","author":"Bovio","year":"2006","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2023061601030595700_dgad044-B2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0889-8529(05)70122-5","article-title":"Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota","volume":"29","author":"Young","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"2023061601030595700_dgad044-B3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"issue":"2","key":"2023061601030595700_dgad044-B4","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023061601030595700_dgad044-B5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2023061601030595700_dgad044-B6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023061601030595700_dgad044-B7","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa270","article-title":"Prevalence and incidence of atrial fibrillation in a large cohort of adrenal incidentalomas: a long-term study","volume":"105","author":"Di Dalmazi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023061601030595700_dgad044-B8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's Syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2023061601030595700_dgad044-B9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"key":"2023061601030595700_dgad044-B10","article-title":"Data from: prevalence of functioning adrenal incidentalomas: a systematic review and meta-analysis","author":"Sconfienza","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2023061601030595700_dgad044-B11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"15","key":"2023061601030595700_dgad044-B12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"9","key":"2023061601030595700_dgad044-B13","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023061601030595700_dgad044-B14","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"issue":"9","key":"2023061601030595700_dgad044-B15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism\u2013the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"issue":"8","key":"2023061601030595700_dgad044-B16","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the working group on endocrine hypertension of the European Society of hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"issue":"6","key":"2023061601030595700_dgad044-B17","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023061601030595700_dgad044-B18","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's Syndrome: an Endocrine Society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"2023061601030595700_dgad044-B19","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.2169\/internalmedicine.0550-17","article-title":"Clinical investigation of adrenal incidentalomas in Japanese patients of the Fukuoka Region with updated diagnostic criteria for sub-clinical Cushing's syndrome","volume":"57","author":"Abe","year":"2018","journal-title":"Intern Med"},{"issue":"4","key":"2023061601030595700_dgad044-B20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3349\/ymj.2018.59.4.501","article-title":"Characteristics of adrenal incidentalomas in a large, prospective computed tomography-based multicenter study: the COAR study in Korea","volume":"59","author":"Ahn","year":"2018","journal-title":"Yonsei Med J"},{"issue":"3","key":"2023061601030595700_dgad044-B21","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1002\/hsr2.22","article-title":"Multidisciplinary approach for patients with functional and non-functional adrenal masses and review of the literature","volume":"1","author":"Akku\u015f","year":"2017","journal-title":"Health Sci Rep"},{"issue":"09","key":"2023061601030595700_dgad044-B22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1055\/s-0029-1237704","article-title":"Long term follow-up of patients with adrenal incidentalomas\u2013a single center experience and review of the literature","volume":"118","author":"Anagnostis","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"2023061601030595700_dgad044-B23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1507\/endocrj.EJ19-0262","article-title":"Comparison between the clinical characteristics of patients with adrenal incidentalomas and those with hypertension-associated adrenal tumors in a single center in Japan","volume":"67","author":"Aoe","year":"2020","journal-title":"Endocr J"},{"issue":"9","key":"2023061601030595700_dgad044-B24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","article-title":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study","volume":"8","author":"Bancos","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2023061601030595700_dgad044-B25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.0.1460061","article-title":"Development of overt Cushing's Syndrome in patients with adrenal incidentaloma","volume":"146","author":"Barzon","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023061601030595700_dgad044-B26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.bjc.6602459","article-title":"Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas","volume":"92","author":"Bernini","year":"2005","journal-title":"Br J Cancer"},{"issue":"1","key":"2023061601030595700_dgad044-B27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0026-0495(97)90176-1","article-title":"Evaluation of hormonal function in a series of incidentally discovered adrenal masses","volume":"46","author":"Bondanelli","year":"1997","journal-title":"Metabolism"},{"issue":"3","key":"2023061601030595700_dgad044-B28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archsurg.1994.01420270067016","article-title":"Subclinical hormone secretion by incidentally discovered adrenal masses","volume":"129","author":"Caplan","year":"1994","journal-title":"Arch Surg"},{"issue":"5","key":"2023061601030595700_dgad044-B29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3904\/kjim.2013.28.5.557","article-title":"Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas","volume":"28","author":"Cho","year":"2013","journal-title":"Korean J Intern Med"},{"issue":"1","key":"2023061601030595700_dgad044-B30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s42000-019-00092-x","article-title":"Patients with extra-adrenal malignancies and adrenal lesions have similar rates of subclinical hypercortisolism compared with patients with true adrenal incidentalomas","volume":"18","author":"Chrisoulidou","year":"2019","journal-title":"Hormones (Athens)"},{"issue":"1","key":"2023061601030595700_dgad044-B31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12020-009-9260-5","article-title":"Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience","volume":"37","author":"Comlekci","year":"2010","journal-title":"Endocrine"},{"issue":"10","key":"2023061601030595700_dgad044-B32","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/ijerph16101872","article-title":"Malignancy risk and hormonal activity of adrenal incidentalomas in a large cohort of patients from a single tertiary reference center","volume":"16","author":"Cyranska-Chyrek","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"2023061601030595700_dgad044-B33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12020-020-02476-1","article-title":"Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study","volume":"71","author":"Falcetta","year":"2021","journal-title":"Endocrine"},{"issue":"8","key":"2023061601030595700_dgad044-B34","first-page":"1054","article-title":"Clinical analysis of 939 patients with adrenal lesions detected by abdominal computed tomography","volume":"37","author":"Fan","year":"2017","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"2","key":"2023061601030595700_dgad044-B35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2265.1995.tb01852.x","article-title":"Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour","volume":"42","author":"Flecchia","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2023061601030595700_dgad044-B36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-09-0957","article-title":"Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas","volume":"162","author":"Giordano","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2023061601030595700_dgad044-B37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imj.13651","article-title":"Characteristics of adrenal incidentalomas in a New Zealand centre","volume":"48","author":"Goh","year":"2018","journal-title":"Intern Med J"},{"issue":"6","key":"2023061601030595700_dgad044-B38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/EJE-17-0372","article-title":"Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice","volume":"177","author":"Hong","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2023061601030595700_dgad044-B39","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.7326\/M20-7946","article-title":"Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas: a cohort study","volume":"174","author":"Kjellbom","year":"2021","journal-title":"Ann Intern Med"},{"issue":"8","key":"2023061601030595700_dgad044-B40","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1575-0922(09)72708-1","article-title":"Incidentalomas suprarrenales: experiencia cl\u00ednica en los hospitales de Castilla-La Mancha [adrenal incidentalomas: clinical experience in the hospitals of Castilla-La Mancha (Spain)]","volume":"56","author":"Lamas","year":"2009","journal-title":"Endocrinol Nutr"},{"key":"2023061601030595700_dgad044-B41","doi-asserted-by":"crossref","first-page":"3093290","DOI":"10.1155\/2017\/3093290","article-title":"Baseline demographic and clinical characteristics of patients with adrenal incidentaloma from a single center in China: a survey","volume":"2017","author":"Li","year":"2017","journal-title":"Int J Endocrinol"},{"issue":"4","key":"2023061601030595700_dgad044-B42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.0.1470489","article-title":"Long-term follow-up study of patients with adrenal incidentalomas","volume":"147","author":"Lib\u00e8","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2023061601030595700_dgad044-B43","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian Society of endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023061601030595700_dgad044-B44","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa263","article-title":"Bone evaluation by high-resolution peripheral quantitative computed tomography in patients with adrenal incidentaloma","volume":"105","author":"Moraes","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023061601030595700_dgad044-B45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2008-1542","article-title":"Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's Syndrome in hospitalized and ambulatory patients","volume":"94","author":"Nunes","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023061601030595700_dgad044-B46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41440-017-0002-4","article-title":"Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors","volume":"41","author":"Ohno","year":"2018","journal-title":"Hypertens Res"},{"issue":"3","key":"2023061601030595700_dgad044-B47","first-page":"826","article-title":"Preclinical Cushing's syndrome in adrenal \u201cincidentalomas\u201d: comparison with adrenal Cushing's syndrome","volume":"75","author":"Reincke","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2023061601030595700_dgad044-B48","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s40618-021-01509-4","article-title":"Depression: another cortisol-related comorbidity in patients with adrenal incidentalomas and (possible) autonomous cortisol secretion","volume":"44","author":"\u0160ojat","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2023061601030595700_dgad044-B49","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/jch.13291","article-title":"Primary aldosteronism in patients with adrenal incidentaloma: is screening appropriate for everyone?","volume":"20","author":"Stavropoulos","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"2023061601030595700_dgad044-B50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1507\/endocrj.EJ15-0404","article-title":"Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan","volume":"63","author":"Tabuchi","year":"2016","journal-title":"Endocr J"},{"issue":"13","key":"2023061601030595700_dgad044-B51","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1055\/s-0031-1291249","article-title":"Outcomes in 125 individuals with adrenal incidentalomas from a single centre. a retrospective assessment of the 1 mg overnight and low dose dexamethasone suppression tests","volume":"43","author":"Theodoraki","year":"2011","journal-title":"Horm Metab Res"},{"issue":"4","key":"2023061601030595700_dgad044-B52","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1530\/eje.0.1440401","article-title":"Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas","volume":"144","author":"Valli","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"2023061601030595700_dgad044-B53","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12902-015-0001-x","article-title":"Limited value of long-term biochemical follow-up in patients with adrenal incidentalomas-a retrospective cohort study","volume":"15","author":"Yeomans","year":"2015","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"2023061601030595700_dgad044-B54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/a-1079-4915","article-title":"Clinical characteristics and follow-up results of adrenal incidentaloma","volume":"129","author":"Yilmaz","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"11","key":"2023061601030595700_dgad044-B55","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2023061601030595700_dgad044-B56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"4","key":"2023061601030595700_dgad044-B57","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/EJE-14-0345","article-title":"Nonconformity in the clinical practice guidelines for subclinical Cushing's Syndrome: which guidelines are trustworthy?","volume":"171","author":"Shen","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2023061601030595700_dgad044-B58","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamasurg.2020.3280","article-title":"Evaluation and treatment of patients with hypercortisolism: a review","volume":"155","author":"Miller","year":"2020","journal-title":"JAMA Surg"},{"issue":"6","key":"2023061601030595700_dgad044-B59","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/endrev\/bnaa008","article-title":"Adrenal incidentaloma","volume":"41","author":"Sherlock","year":"2020","journal-title":"Endocr Rev"},{"key":"2023061601030595700_dgad044-B60","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","article-title":"Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review","volume":"51","author":"Berends","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"1","key":"2023061601030595700_dgad044-B61","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1038\/s41598-022-06655-0","article-title":"Predictive model of pheochromocytoma based on the imaging features of the adrenal tumours","volume":"12","author":"Araujo-Castro","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"2023061601030595700_dgad044-B62","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1210\/jc.2012-1061","article-title":"Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?","volume":"97","author":"Sane","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023061601030595700_dgad044-B63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41574-021-00543-9","article-title":"Machine intelligence in non-invasive endocrine cancer diagnostics","volume":"18","author":"Thomasian","year":"2022","journal-title":"Nat Rev Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad044\/49228795\/dgad044.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/7\/1813\/50604503\/dgad044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/7\/1813\/50604503\/dgad044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T02:02:53Z","timestamp":1686880973000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/7\/1813\/7015785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":63,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,1,31]]},"published-print":{"date-parts":[[2023,6,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad044","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,1,31]]}}}